These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9724460)

  • 21. Effects of Osteogenic-Conditioned Medium from Human Periosteum-Derived Cells on Osteoclast Differentiation.
    Park HC; Son YB; Lee SL; Rho GJ; Kang YH; Park BW; Byun SH; Hwang SC; Cho IA; Cho YC; Sung IY; Woo DK; Byun JH
    Int J Med Sci; 2017; 14(13):1389-1401. PubMed ID: 29200953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: an in vitro and in vivo study.
    Guillerminet F; Beaupied H; Fabien-Soulé V; Tomé D; Benhamou CL; Roux C; Blais A
    Bone; 2010 Mar; 46(3):827-34. PubMed ID: 19895915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wedelolactone inhibits osteoclastogenesis but enhances osteoblastogenesis through altering different semaphorins production.
    Deng X; Liang LN; Zhu D; Zheng LP; Yu JH; Meng XL; Zhao YN; Sun XX; Pan TW; Liu YQ
    Int Immunopharmacol; 2018 Jul; 60():41-49. PubMed ID: 29702282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pamidronate on human alveolar osteoblasts in vitro.
    Marolt D; Cozin M; Vunjak-Novakovic G; Cremers S; Landesberg R
    J Oral Maxillofac Surg; 2012 May; 70(5):1081-92. PubMed ID: 21856057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
    Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
    Faucheux C; Verron E; Soueidan A; Josse S; Arshad MD; Janvier P; Pilet P; Bouler JM; Bujoli B; Guicheux J
    J Biomed Mater Res A; 2009 Apr; 89(1):46-56. PubMed ID: 18404716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
    Huang J; Yuan L; Wang X; Zhang TL; Wang K
    Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granules.
    Gamblin AL; Renaud A; Charrier C; Hulin P; Louarn G; Heymann D; Trichet V; Layrolle P
    Acta Biomater; 2014 Dec; 10(12):5139-5147. PubMed ID: 25196309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-Culture with Human Osteoblasts and Exposure to Extremely Low Frequency Pulsed Electromagnetic Fields Improve Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.
    Ehnert S; van Griensven M; Unger M; Scheffler H; Falldorf K; Fentz AK; Seeliger C; Schröter S; Nussler AK; Balmayor ER
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
    Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
    J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoclastogenesis is negatively regulated by D-serine produced by osteoblasts.
    Takarada T; Takarada-Iemata M; Takahata Y; Yamada D; Yamamoto T; Nakamura Y; Hinoi E; Yoneda Y
    J Cell Physiol; 2012 Oct; 227(10):3477-87. PubMed ID: 22252936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
    Dela Cruz A; Grynpas MD; Mitchell J
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts.
    Schwartz Z; Lohmann CH; Wieland M; Cochran DL; Dean DD; Textor M; Bonewald LF; Boyan BD
    J Periodontol; 2000 Apr; 71(4):586-97. PubMed ID: 10807123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
    Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
    J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.
    Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
    Arch Med Res; 2013 Jul; 44(5):325-34. PubMed ID: 23867791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of RANKL-induced osteoclastic differentiation by vascular cells.
    Tintut Y; Abedin M; Cho J; Choe A; Lim J; Demer LL
    J Mol Cell Cardiol; 2005 Aug; 39(2):389-93. PubMed ID: 15893766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfated glycosaminoglycans support osteoblast functions and concurrently suppress osteoclasts.
    Salbach-Hirsch J; Ziegler N; Thiele S; Moeller S; Schnabelrauch M; Hintze V; Scharnweber D; Rauner M; Hofbauer LC
    J Cell Biochem; 2014 Jun; 115(6):1101-11. PubMed ID: 24356935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.